Open AccessOR34-4 ATF3 Is A Converging Point For AR Signaling And Fatty Acid Oxidation In Prostate Cancer
Author(s) -
Molishree Joshi,
Maren Salzmann-Sullivan,
Isabel R. Schlaepfer
Publication year - 2019
Publication title -
journal of the endocrine society
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.046
H-Index - 20
ISSN - 2472-1972
DOI - 10.1210/js.2019-or34-4
Subject(s) - lncap , prostate cancer , gene knockdown , enzalutamide , cancer research , androgen , medicine , downregulation and upregulation , androgen deprivation therapy , tramp , atf3 , endocrinology , androgen receptor , cancer , biology , cell culture , gene expression , gene , biochemistry , hormone , genetics , promoter
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom